Cargando…

The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation

Neuroinflammation, which is involved in various inflammatory cascades in nervous tissues, can result in persistent and chronic apoptotic neuronal cell death and programmed cell death, triggering various degenerative disorders of the central nervous system (CNS). The neuroprotective effects of natura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khadka, Bikram, Lee, Jae-Young, Park, Dong Ho, Kim, Ki-Taek, Bae, Jong-Sup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601486/ https://www.ncbi.nlm.nih.gov/pubmed/33019651 http://dx.doi.org/10.3390/biom10101401

Ejemplares similares

Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders
por: Khadka, Bikram, et al.
Publicado: (2021)

Nanocarriers for Delivery of Oligonucleotides to the CNS
por: Male, David, et al.
Publicado: (2022)

Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems
por: Rakotondrabe, Tojofaniry Fabien, et al.
Publicado: (2023)

Nanogels as novel drug nanocarriers for CNS drug delivery
por: Manimaran, V., et al.
Publicado: (2023)

Drug Delivery Systems for Personal Healthcare by Smart Wearable Patch System
por: Khadka, Bikram, et al.
Publicado: (2023)

Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation
por: Stan, Diana, et al.
Publicado: (2021)

Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics
por: Zhang, Yunhan, et al.
Publicado: (2022)

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
por: Maher, Rebecca, et al.
Publicado: (2023)

Natural Antioxidant and Anti-Inflammatory Compounds in Foodstuff or Medicinal Herbs Inducing Heme Oxygenase-1 Expression
por: Hahn, Dongyup, et al.
Publicado: (2020)

Microarray Screening for Genes Involved in Oligodendrocyte Differentiation in the Zebrafish CNS
por: Chung, Ah-Young, et al.
Publicado: (2011)

Role of BET Proteins in Inflammation and CNS Diseases
por: Liu, Lei, et al.
Publicado: (2021)

Nanocarriers containing platinum compounds for combination chemotherapy
por: Fang, Guihua, et al.
Publicado: (2022)

Protective Effects of Cirsilineol against Lipopolysaccharide-Induced Inflammation; Insights into HO-1, COX-2, and iNOS Modulation
por: Kim, Go Oun, et al.
Publicado: (2023)

Natural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a Target
por: Gothai, Sivapragasam, et al.
Publicado: (2016)

Alleviation effects of natural volatile organic compounds from Pinus densiflora and Chamaecyparis obtusa on systemic and pulmonary inflammation
por: Ahn, Changhwan, et al.
Publicado: (2018)

Inorganic Nanocarriers for Encapsulation of Natural Antimicrobial Compounds for Potential Food Packaging Application: A Comparative Study
por: Gulin-Sarfraz, Tina, et al.
Publicado: (2021)

Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers
por: Teixeira, Patrícia V., et al.
Publicado: (2023)

Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
por: Zeb, Alam, et al.
Publicado: (2020)

The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
por: Vezzani, Bianca, et al.
Publicado: (2020)

Nanoparticles: A Hope for the Treatment of Inflammation in CNS
por: Zhu, Feng-Dan, et al.
Publicado: (2021)

Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds
por: He, Junyao, et al.
Publicado: (2022)

Astrocyte Regulation of CNS Inflammation and Remyelination
por: Claycomb, Kumiko I., et al.
Publicado: (2013)

Neurotrauma and Inflammation: CNS and PNS Responses
por: Mietto, Bruno Siqueira, et al.
Publicado: (2015)

Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis
por: Gorshkov, Andrey, et al.
Publicado: (2022)

Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
por: Ji, Weihong, et al.
Publicado: (2023)

Correlation between the Crosslink Characteristics and Mechanical Properties of Natural Rubber Compound via Accelerators and Reinforcement
por: Kim, Do Young, et al.
Publicado: (2020)

Role and Merits of Green Based Nanocarriers in Cancer Treatment
por: Elbagory, Abdulrahman M., et al.
Publicado: (2021)

Editorial: Current challenges in inflammation and pain biology: The role of natural and synthetic compounds
por: Fernandes, Elizabeth Soares, et al.
Publicado: (2022)

Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
por: Tan, Qingqin, et al.
Publicado: (2021)

Novel Surface-Modified Bilosomes as Functional and Biocompatible Nanocarriers of Hybrid Compounds
por: Waglewska, Ewelina, et al.
Publicado: (2020)

Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound
por: Xu, Junxin, et al.
Publicado: (2023)

Prevalence of Thyroid Dysfunction Among Depression Patients in a Tertiary Care Centre
por: Kafle, Bikram, et al.
Publicado: (2020)

Dendrimers as Nanocarriers for the Delivery of Drugs Obtained from Natural Products
por: An, Huan, et al.
Publicado: (2023)

Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
por: Guo, Zi-Hua, et al.
Publicado: (2023)

The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS
por: Mukandala, Gatambwa, et al.
Publicado: (2016)

EGFL7 reduces CNS inflammation in mouse
por: Larochelle, Catherine, et al.
Publicado: (2018)

Glycemic Variability and CNS Inflammation: Reviewing the Connection
por: Watt, Charles, et al.
Publicado: (2020)

Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
por: Din, Fakhar ud, et al.
Publicado: (2017)

MOSPD2 is a therapeutic target for the treatment of CNS inflammation
por: Yacov, N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ioi040rqmucvmck188a43qilqj